Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

942
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
942
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

193
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
193
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flexible, multimodal, electrical-sensing-optical-transmission μfiber-sensors via an on-fiber printed electronics strategy.

National science review·2026
Same author

Research progress and applications of functional hydrogels in nasal wound healing.

Journal of biological engineering·2026
Same author

Astrocyte-derived exosome-mediated siRNA delivery combined with quercetin-Mn complex promotes neural repair in spinal cord injury.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

3D craniofacial generative model for surgical planning in mandibular reconstruction.

Medical image analysis·2026
Same author

Cigarette Smoke-Induced ClC-3 Deficiency Drives Chronic Bronchitis via the AKT/CREB1 Axis and Lysosomal-Autophagic Impairment.

Free radical biology & medicine·2026
Same author

Deep learning-based diagnosis of parotid gland tumors on CT images: A multi-view approach for preoperative differentiation of benign and malignant lesions.

Journal of stomatology, oral and maxillofacial surgery·2026
Same journal

PFASGroups: An Open-Source Framework for Automated Identification, Structural Classification, and Prioritization of Per- and Polyfluoroalkyl Substances.

Journal of chemical information and modeling·2026
Same journal

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
Same journal

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K

HGANMDA: A Heterogeneous Graph Adversarial Network for Multimodal Microbe-Drug Association Prediction.

Dong Ye1,2, Ziliang Li3, Susu Cui4

  • 1The School of Computer Science and Technology, Soochow University, Suzhou 215006, China.

Journal of Chemical Information and Modeling
|December 17, 2025
PubMed
Summary
This summary is machine-generated.

Predicting microbe-drug associations (MDAs) is crucial for antimicrobial therapy. A new heterogeneous graph adversarial network (HGANMDA) improves prediction accuracy by capturing complex biological network patterns.

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Area of Science:

  • Biomedical informatics
  • Computational biology
  • Network pharmacology

Background:

  • Accurate microbe-drug association (MDA) prediction is essential for antimicrobial therapy and drug repositioning.
  • Experimental validation is costly and time-consuming.
  • Existing models struggle with heterogeneous and multiscale biomedical network interactions.

Purpose of the Study:

  • To develop an advanced computational model for predicting microbe-drug associations.
  • To address limitations of current methods in capturing complex biological network structures.

Main Methods:

  • Developed HGANMDA, a heterogeneous graph adversarial network.
  • Integrated multimodal biological data into a unified heterogeneous graph.
  • Employed a multichannel structural encoder with attention-based aggregation.
  • Introduced adversarial embedding regularization for enhanced robustness and feature separability.

Main Results:

  • HGANMDA consistently outperformed state-of-the-art baseline models across multiple metrics on three benchmark datasets.
  • Demonstrated superior performance in predicting microbe-drug associations.
  • Validated the effectiveness of the proposed heterogeneous graph learning approach.

Conclusions:

  • Adversarially regularized heterogeneous graph learning shows significant potential for advancing antimicrobial research.
  • HGANMDA offers a robust and accurate method for predicting microbe-drug associations.
  • The findings support the use of advanced network learning techniques in drug discovery and development.